Debates & Insight Sponsored New report: Are clinical trials under threat from ‘system ov... The 2017 Unified Clinical Operations Survey Report
Views & Analysis A European perspective on oncology: ASCO review An overview of the latest on immunotherapies, progress in multiple myeloma and benefits of patient-reported outcomes.
News Andexxa reaches the end of the line in the US AstraZeneca will voluntarily take its anticoagulant reversal agent Andexxa off the market in the US amid reports of serious clotting side effects.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
